A team at UT Southwestern Medical Center has identified a structural trick that lets viruses translate their genetic code inside human cells, even when that code is riddled with “bad” codons the host ...

The use of the nucleic acid platform for antigen delivery has expanded rapidly in the past decade, highlighted by the development and deployment of several nucleic acid vaccines for SARS-CoV-2 and the ...

Paul Conyngham's 8-year-old rescue dog had a fatal skin cancer. He turned to AI to see if he could create a personalized anti ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an update on its ongoing regulatory interactions with the U.S. Food and Drug ...

Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...

"Falling vaccination rates, inadequate health policy, and a lack of preparedness can trigger a crisis that brings an entire nation to its knees," writes the Governor of Hawaii.

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise.

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines in areas of high unmet need in rare muscle diseases, ...

At first glance this was huge news with chemical implications: $300 billion would be an extraordinary investment for a refinery, many times more than was put into China’s giant Zhejiang Petroleum and ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...